Keith Michael Gottesdiener, CEO and President at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 31,453 shares at $30.05 ($945K) on 2019-01-22, disclosed to the SEC on 2019-01-24.
Open-market sale of $945k RYTM by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.05 | 15,674 | $471K | 49.8% |
| 2 | $30.05 | 15,674 | $471K | 49.8% |
| 3 | $30.21 | 105 | $3K | 0.3% |
| Total | $30.05 avg | 31,453 | $945K | 100% |
| Filing → |
| RYTM | SELL | 2019-02-28 | $128K | — | Filing → |
| RYTM | SELL | 2019-02-20 | $748K | — | Filing → |
| RYTM | SELL | 2019-02-15 | $118K | — | Filing → |